Pedestrians outside the Nasdaq MarketSite in New York, US, on Friday, Oct. 16, 2026. City Therapeutics Inc., an early-stage developer of RNAi-based drugs, raised $200 million in a US initial public offering priced at the mid-point of its marketed range. Photographer: Michael Nagle/Bloomberg via Getty Images
Pedestrians outside the Nasdaq MarketSite in New YorkMichael Nagle/Bloomberg via Getty Images

Nasdaq tumbles while treasuries soar as Meta rekindles AI spending fears

Meta’s plans to raise hundreds of billions for AI sparked a $124bn market value loss and tech sell-off.
Published on: 
Loading content, please wait...
BizNews
www.biznews.com